Nonetheless, the role of TrkC as a tumor suppressor in the pathogenesis of CRC has been limited by our finding that TrkC enhances the tumorigenicity and metastasis of CRC by activation of AKT signaling and suppression of transforming growth factor (TGF)-β signaling [16]. This evidence concerns the gene NTRK3 and colorectal carcinoma.